Operative morbidity and mortality after D2 and D4 extended dissection for advanced gastric cancer: A prospective randomized trial conducted by Asian surgeons

Hepato-Gastroenterology

Volumn 53, Issue 69, 2006, Pages 389-394

  Yonemura, Yutaka ^a   Wu, C C ^b   Fukushima, N ^c   Honda, I ^d   Bandou, E ^a,k   Kawamura, T ^a   Kamata, S ^e   Yamamoto, H ^f   Kim, B S ^g   Matsuki, N ^h   Sawa, T ⁱ   Noh, S H ^j  

^a SHIZUOKA CANCER CENTER   (Japan)

^b TAICHUNG VETERANS GENERAL HOSPITAL   (Taiwan)

^c Yamagata Prefectural Central Hospital   (Japan)

^d CHIBA CANCER CENTER   (Japan)

^e Division of Neurosurgery   (Japan)

^f FUKUI PREFECTURAL HOSPITAL   (Japan)

^g Ulsan University College of Medicine   (South Korea)

^h Toyama Rosai Hospital   (Japan)

ⁱ Turuga National Sanatorium Hospital   (Japan)

^j Yonsei University   (South Korea)

^k NATIONAL HOSPITAL ORGANIZATION   (Japan)

more..

Author keywords

D2 gastrectomy; D4 gastrectomy; Gastrectomy; Gastric cancer; Lymphadenectomy; Paraaortic lymph nodes

Indexed keywords

ABDOMINAL ABSCESS; ADULT; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DEMOGRAPHY; FEMALE; GASTRECTOMY; HUMAN; LYMPHADENECTOMY; MAJOR CLINICAL STUDY; MALE; MORBIDITY; MORTALITY; OPERATION DURATION; PANCREAS FISTULA; PARAAORTIC LYMPH NODE; POSTOPERATIVE COMPLICATION; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SPLENECTOMY; STOMACH CANCER; STOMACH RUPTURE; SURGEON;

ABDOMINAL ABSCESS; ADENOCARCINOMA; ASIA; FEMALE; GASTRECTOMY; HUMANS; INCIDENCE; LYMPH NODE EXCISION; LYMPHATIC METASTASIS; MALE; MIDDLE AGED; MORBIDITY; PANCREATIC FISTULA; POSTOPERATIVE COMPLICATIONS; PROSPECTIVE STUDIES; STOMACH NEOPLASMS; SURVIVAL ANALYSIS; TIME FACTORS;

EID: 33745436728     PISSN: 01726390     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (31)

1. Leichman L, Silberman H, Leichman CG, et al: Postoperative systemic chemotherapy followed by adjuvant postoperative intraperitoneal therapy for gastric cancer. A Universiy of Southern California pilot program. J Clin Oncol 1992; 10:1933-1942.
2. Ajani JA, Mayer R, Ota DM, et al: Preoperative and postoperative combination chemotherapy for potentially resectable gastric carcinoma. J Natl Cancer Inst 1993; 85:1839-1844.
3. Heberer G, Teichman RK, Kramling H-J, et al: Results of gastric resection for carcinoma of the stomach. The European experience. World J Surg 1988; 12:374-381.
4. Wanebo H, Kennedy B, Chimel J, et al: Cancer of the stomach: A patient care study by the American College of Surgeons. Ann Surg 1993; 218:583-592.
5. Japanese research Society for Gastric Cancer: The general rules for the gastric cancer study in surgery and pathology. 12th Edition. Tokyo, Kanehara Shuppan, 1993.
6. Yonemura Y, Segawa M, Matsumoto H, et al: Surgical results of performing R4 gastrectomy for gastric cancer located in the upper third of the stomach. Jpn J Surg 1994; 24:488-493.
7. Hsu CP, Wu CC, Chen CY, et al: Clinical experience in radical lymphadenectomy for adenocarcinoma of the gastric cardia. J Thorac Cardiovasc Surg 1997; 114:544-551.
8. Yoo CH, Noh SH, Shin DW, et al: Recurrence following curative resection for gastric carcinoma. Br J Surg 2000; 87:236-242.
9. De Aretxabala X, Konishi K, Yonemura Y, et al: Node dissection in gastric cancer. Br J Surg 1987; 74:770-777.
10. Bonenkamp JJ, Songu I, Herman J, et al: Randomized comparison of mortality after D1 and D2 dissection for gastric cancer in 996 Dutch patients. Lancet 1995; 345:745-748.
11. Cuschieri A, Fayers P, Fielding J, et al: Postoperative morbidity and mortality after D1 and D2 resections for gastric cancer: Preliminary results of the MTC randomised controlled surgical trial. Lancet 1996; 347:995-999.
12. Viste AV, Haugstvedt T, Eide GE, et al: The Norwegian Stomach Cancer Trial Member. Ann Surg 1988; 207:7-13.
13. Macdonald JS, Smalley SR, Benedetti, et al: Chemoradiotherapy after surgery compared with surgery alone for adenocarcinoma of the stomach or gastroesophageal junction. NEJM 2001; 345:725-730.
14. Maruyama K, Okabayashi K: Progress in gastric cancer surgery in Japan. World J Surg 1987; 11:418-425.
15. Sue-Ling HM, Johnston G, Martin IG, et al: Gastric cancer: a curable disease in Britain. BMJ 1993; 307:591-596.
16. Csendes A, Buordilis P, Rojas J, et al: A prospective randomized study comparing D2 total gastrectomy versus D2 total gastrectomy plus splenectomy in 187 patients with gastric carcinoma. Surgery 2002; 131:401-407.
17. Nakajima T, Nishi M: Surgery and adjuvant chemotherapy for gastric cancer. Hepatogastroenterology 1989; 36:79-85.
18. Smith JW, Shiu MH, Kelsey L, et al: Morbidity of radical lymphadenectomy in the curative resection of gastric carcinoma. Arch Surg 1991; 126:1469-1473.
19. Shiu MH, Moore E, Sander M, et al: Influence of the extent of resection on survival after curative treatment of gastric cancer. Arch Surg 1987; 122:1347-1351.
20. Yonemura Y: Extended radical gastrectomy: its indication and results. In: Yonemura Y. (Ed.). Contemporary approaches toward cure of gastric cancer. Kanazawa, Japan: Maeda Shoten, 1996; pp. 56-60.
21. Sasako M, McCulloch P, Kinoshita T, et al: New method to evaluate the therapeutic value of lymph node dissection for gastric cancer. Br J Surg 1995; 82:346-351.
22. Martin RCG, Jaques DP, Brennan MF, et al: Extended local resection for advanced gastric cancer. Ann Surg 2002; 236:259-265.
23. Roder J, Bottcher K, Siewert R, et al: the German Gastric Carcinoma Study Group. Prognostic factors in gastric cancer. Cancer 1993; 72:2089-2097.
24. Kunisaki C, Shimada H, Yamaoka H, et al: Significance of para-aortic lymph node dissection in advanced gastric cancer. Hepatogastroenterology 1994; 46:2635-2642.
25. Isozaki H, Okajima K, Fujii K: Histological evaluation of lymph node metastasis on serial sectioning in gastric cancer with radical lymphadenectomy. Hepatogastroenterology 1997; 44:1133-1136.
26. Kwon SJ: Prognostic impact of splenectomy on gastric cancer: results of a Korea gastric cancer study group. World J Surg 1997; 21:837-844.
27. Robertson CS, Chung SSC, Woods SDS, Griffin AM, et al: A prospective randomized trial comparing R1 subtotal gastrectomy with R3 total gastrectomy for antral cancer. Ann Surg 1994; 220:176-182.
28. DiLeo A, Pedrazzani C, Bonfiglio M, et al: La linfadenectomia superestesa (D4) nel trattamento dell'adenocarcinoma gastrico. Minerva Chir 2002; 57:641-647.
29. Sano T, Sasako M, for the gastric Cancer Surgical Study Group of the Japan Clinical Oncology Group (JCOG), Japan: Randomized controlled trial to evaluate para-aortic lymphadenectomy for gastric cancer (JCOG 9502): An update. 4th International Gastric cancer Congress, 2001; abstracts, p. 663.
30. Wu CW, Hsiung CA, Lo SS, et al: Randomized clinical trial of morbidity after D1 and D3 surgery for gastric cancer. Brit J Surg 2004; 91:283-287.
31. UICC International Union Against Cancer: TNM Classification of Malignant Tumours. Sobin LH, Wittekind Ch (Eds.). Sixth Edition, A John Wiley & Sons, Inc., Publication. Stomach (ICD-O C16), 2002; pp. 65-67.